Skip to main content
. 2022 Nov 23;2022(11):CD010612. doi: 10.1002/14651858.CD010612.pub3

Comparison 3. Subgroup analysis: death or non‐recovery of kidney function at day 90.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
3.1 AKI aetiology 6 4011 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.74, 1.11]
3.1.1 Non‐surgical causes 3 3646 Risk Ratio (M‐H, Random, 95% CI) 1.04 [0.97, 1.11]
3.1.2 Surgical causes 3 365 Risk Ratio (M‐H, Random, 95% CI) 0.66 [0.33, 1.33]
3.2 AKI criteria 6 4011 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.74, 1.11]
3.2.1 KDIGO stage 2 1 619 Risk Ratio (M‐H, Random, 95% CI) 0.95 [0.79, 1.15]
3.2.2 KDIGO stage 3/RIFLE‐F AKIN 3 3258 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.70, 1.19]
3.2.3 Other criteria 2 134 Risk Ratio (M‐H, Random, 95% CI) 0.47 [0.07, 3.21]
3.3 KRT modality 6 4011 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.74, 1.11]
3.3.1 Continuous KRT 3 365 Risk Ratio (M‐H, Random, 95% CI) 0.66 [0.33, 1.33]
3.3.2 Continuous and intermittent KRT 3 3646 Risk Ratio (M‐H, Random, 95% CI) 1.04 [0.97, 1.11]
3.4 Illness severity score 5 3983 Risk Ratio (M‐H, Random, 95% CI) 0.96 [0.83, 1.10]
3.4.1 Sequential Organ Failure Assessment (SOFA) score > 12 2 331 Risk Ratio (M‐H, Random, 95% CI) 0.77 [0.62, 0.97]
3.4.2 Sequential Organ Failure Assessment (SOFA) score ≤ 12 3 3652 Risk Ratio (M‐H, Random, 95% CI) 1.04 [0.97, 1.12]